journal article·2017

Synthesis of α-amino-lipophosphonates as cationic lipids or co-lipids for DNA transfection in dendritic cells

Mathieu Berchel, Sohail Akhter, Wilfried Berthe, Cristine Gonçalves, Marine Dubuisson, Chantal Pichon, Paul-Alain Jaffrès, Patrick Midoux

Journal of Materials Chemistry B· Volume 5· Issue 33
Publisher page

Abstract

Cationic lipid/co-lipid combinations have been extensively explored in gene delivery as alternatives to viral vectors. To be established as a gold standard of chemical vectors, considerable improvement in their transfection efficiency is however required. Herein, we report a simple procedure to synthesize new cationic lipids and co-lipids for the DNA transfection of dendritic cells (DCs). Seven α-amino-lipophosphonates featuring two aza-heterocycles with protonable sites (imidazole or pyridine) were synthesized and used as co-lipids in liposomes with cationic lipids. For each liposome, the cationic lipid is either an imidazolium lipophosphoramidate (lipid 2) or an α-amino-lipophosphonate containing a basic tertiary aliphatic amine in the polar head group (lipid 3b). The cationic lipids either with new co-lipids or DOPE formed positively charged nano-sized stable liposomes that effectively interact with plasmid DNA (pDNA) to produce lipoplexes. Membrane fusion studies showed that α-amino-phosphonates featuring an imidazole moiety in the polar head group exhibited higher fusion at pH 5.5 than pH 7.4. This study suggests that the best formulations for the transfection of DCs (based on the % transfected cells and the intensity of EGFP-based fluorescence) are lipid 2 associated with either 3a, 3d or DOPE and cationic lipid 3b formulated with 3a or DOPE as a helper lipid. Furthermore, lipid 3a could be used as an alternative to DOPE as a helper lipid. Overall, these results indicate that novel imidazole containing α-amino-phosphonates can serve as effective transfection agents for DC-based vaccines.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Viral Infections and Immunology Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

CEMCA

UMR CNRS 6521

University of Brest

IBSAM

6 Avenue Victor Le Gorgeu

Centre de Biophysique Moléculaire

CNRS UPR4301

rue Charles Sadron CS 80054 F-45071 Orléans Cedex 02 and University of Orléans

France

Le Studium® Loire Valley Institute for Advanced Studies

References (37)

Show source-provided references
1. Santiago-Ortiz · J. Controlled Release · 2016 · 240 · 28710.1016/j.jconrel.2016.01.001 ↗
2. Ginn · J. Gene Med. · 2013 · 15 · 6510.1002/jgm.2698 ↗
3. Yin · Nat. Rev. Genet. · 2014 · 15 · 54110.1038/nrg3763 ↗
4. Bilton · Lancet Respir. Med. · 2015 · 3 · e2010.1016/S2213-2600(15)00234-9 ↗
5. Meyer · Hum. Gene Ther. · 2006 · 17 · 106210.1089/hum.2006.17.1062 ↗
6. Hardee · Genes · 2017 · 8 · 6510.3390/genes8020065 ↗
7. Midoux · Br. J. Pharmacol. · 2009 · 157 · 16610.1111/j.1476-5381.2009.00288.x ↗
8. Mintzer · Chem. Rev. · 2009 · 109 · 25910.1021/cr800409e ↗
9. Lindberg · Biomaterials · 2015 · 59 · 110.1016/j.biomaterials.2015.04.024 ↗
10. Huang · Org. Biomol. Chem. · 2015 · 13 · 62010.1039/C4OB01856G ↗
11. Mochizuki · Biochim. Biophys. Acta, Biomembr. · 2013 · 1828 · 41210.1016/j.bbamem.2012.10.017 ↗
12. Du · Sci. Rep. · 2014 · 4 · 710710.1038/srep07107 ↗
13. Fletcher · Org. Biomol. Chem. · 2006 · 4 · 19610.1039/B514532E ↗
14. Dal-Maso · Eur. J. Med. Chem. · 2008 · 43 · 175810.1016/j.ejmech.2007.11.002 ↗
15. Lamarche · Bioconjugate Chem. · 2007 · 18 · 157510.1021/bc070070w ↗
16. Fraix · Org. Biomol. Chem. · 2013 · 11 · 165010.1039/c3ob27261c ↗
17. Le Corre · Org. Biomol. Chem. · 2015 · 13 · 112210.1039/C4OB01770F ↗
18. Mével · ChemBioChem · 2008 · 9 · 146210.1002/cbic.200700727 ↗
19. Mével · J. Gene Med. · 2016 · 18 · 310.1002/jgm.2869 ↗
20. Perche · J. Drug Targeting · 2011 · 19 · 31510.3109/1061186X.2010.504262 ↗
21. Gonalves · Int. J. Pharm. · 2014 · 460 · 26410.1016/j.ijpharm.2013.11.005 ↗
22. Perche · Nanomedicine · 2011 · 7 · 44510.1016/j.nano.2010.12.010 ↗
23. Gonalves · Mol. Pharmaceutics · 2016 · 13 · 315310.1021/acs.molpharmaceut.6b00376 ↗
24. Boduszek · Tetrahedron · 2012 · 68 · 122310.1016/j.tet.2011.11.054 ↗
25. Mevel · Chem. Commun. · 2008 · 312410.1039/b805226c ↗
26. Berchel · Biochimie · 2012 · 94 · 3310.1016/j.biochi.2011.07.026 ↗
27. Shen · J. Immunol. · 1997 · 158 · 272310.4049/jimmunol.158.6.2723 ↗
28. Kumar · Gene Ther. · 2003 · 10 · 120610.1038/sj.gt.3301979 ↗
29. Keglevich · Molecules · 2012 · 17 · 1282110.3390/molecules171112821 ↗
30. Rafael'A · Russ. Chem. Rev. · 1998 · 67 · 85710.1070/RC1998v067n10ABEH000421 ↗
31. Stoikov · Russ. Chem. Bull. · 2004 · 53 · 157710.1023/B:RUCB.0000046257.44290.84 ↗
32. Mevel · Bioconjugate Chem. · 2007 · 18 · 160410.1021/bc070089z ↗
33. Pietri · J. Biol. Chem. · 2000 · 275 · 1950510.1074/jbc.M001784200 ↗
34. Zhang · Biochimie · 2012 · 94 · 4210.1016/j.biochi.2011.05.005 ↗
35. Ciani · Biochim. Biophys. Acta, Biomembr. · 2004 · 1664 · 7010.1016/j.bbamem.2004.04.003 ↗
36. Montier · Curr. Gene Ther. · 2008 · 8 · 29610.2174/156652308786070989 ↗
37. Kranz · Nature · 2016 · 534 · 39610.1038/nature18300 ↗